Projects

senior scientist
MUDr. Táňa Ravingerová, DrSc., FIACS

International

Current
  • EUropean network to tackle METAbolic alterations in HEART failure
    Program: COST
    Duration: 18. 10. 2023 – 17. 10. 2027
Finished
  • Realising the therapeutic potential of novel cardioprotective therapies
    Program: COST
    Duration: 19. 10. 2017 – 18. 4. 2022
  • Study of the triggering mechanisms and transmission of cardioprotective signals induced by noninvasive adaptive stimuli
    Program: Inter-academic agreement
    Duration: 1. 1. 2018 – 31. 12. 2020
  • Effect of pathological states on cardiac resistance against myocardial ischemia: study of molecular mechanisms and novel approaches to cardioprotection
    Program: Inter-academic agreement
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Study of cellular and molecular mechamisms involved in cardioprotective effects of red palm oil.
    Program: Bilateral - other
    Duration: 1. 1. 2010 – 31. 12. 2015
  • Study of clinically applicable novel forms of preconditioning as an alternative method of cardiac protection against acute ischemia in the organism challenged with civilization diseases
    Program: Inter-governmental agreement
    Duration: 1. 1. 2015 – 31. 12. 2015
  • Intracellular signaling pathways and nuclear transcription factor activation in cardiac adaptation to ischemia/reperfusion injury
    Program: Bilateral - other
    Duration: 1. 1. 2011 – 31. 12. 2015
  • Study of endogenous cardioprotective mechanisms against myocardial ischemia
    Program: Inter-academic agreement
    Duration: 1. 1. 2009 – 31. 12. 2014
  • IVF grant New Frontiers in Basic Cardiovascular Research 2014
    Program: Other
    Duration: 1. 2. 2014 – 30. 7. 2014
  • The effect of lifestyle-related risk factors on the intrinsic defensive mechanisms in the myocardium
    Program: Inter-governmental agreement
    Duration: 1. 1. 2012 – 31. 12. 2013
  • Chronic ischemic injury of the heart: Influence of ionizing radiation on cardiovascular system and possibilities to minimize its adverse effect
    Program: Bilateral - other
    Duration: 1. 1. 2007 – 31. 12. 2012
  • Study of the adaptive mechanisms in the heart during ischemic injury: novel possibilities of cardioprotection.
    Program: Inter-academic agreement
    Duration: 1. 6. 2010 – 30. 5. 2011
  • Activation of cellular adaptive processes as a potential target of cardiac protection against ischaemic injury
    Program: Inter-governmental agreement
    Duration: 1. 1. 2008 – 1. 12. 2009
  • Protection of ischemic myocardium
    Program: Inter-institute agreement
    Duration: 1. 1. 2006 – 31. 12. 2008
  • -
    Program: Inter-academic agreement
    Duration: 1. 1. 2007 – 31. 12. 2008
  • Modulation of the cardiac icshemic tolerance : the role of endogenous cardioprotective mechanisms.
    Program: Inter-governmental agreement
    Duration: 1. 1. 2006 – 31. 12. 2007
  • Novel agents for limiting endothelial injury in diabetes mellitus
    Program: NATO
    Duration: 1. 1. 2005 – 31. 12. 2007
  • Intracellular Signalling Pathways and Transcription Factor Activation in Cardiac Adaptation to Ischemia/Reperfusion Injury
    Program: Inter-governmental agreement
    Duration: 1. 1. 2005 – 31. 12. 2006

National

Current
  • Study of the role of innate cardioprotection in the rat myocardium evoked by non-pharmacological adaptive stimuli under normal and pathological conditions.
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
  • Necroptotic and pleiotropic effects of RIP3 kinase acting as a convergent point in cardiac cell loss: understanding the basic mechanisms in the ischemic heart with or without metabolic stress as a tool for designing therapeutic approaches.
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
Finished
  • The role of miRNAs in the onset and progression of cardiovascular diseases - new approach to the protection of the heart in situations of increased production of reactive oxygen species
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • The role of non-ischemic adaptive stimuli in protection of ischemic myocardium: study of triggering mechanisms and cardioprotective cell signaling
    Program: SRDA
    Duration: 1. 7. 2019 – 30. 6. 2024
  • Crosslinking of some necrosis-like forms of cell death: signaling and a multi-targeting tool to mitigate heart damage due to ischemia?
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Heart protection in situations of excessive formation of oxygen and nitrosyl radicals: Molecular hydrogen as a new potential therapeutic tool?
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Study of triggering factors and signal transduction mechanisms induced by noninvasive adaptive interventions in rats aimed to protect myocardium against schemia
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Research of magnetic forms of iron in development of cardiovascular diseases and behavioural disorders
    Program: SRDA
    Duration: 1. 7. 2017 – 30. 6. 2021
  • Dynamics of myocardial damage: a role of necroptotic cell death and survival of cardiomyocytes.
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • Hypoxia in the prevention of heart failure in rats and its influence in various stages of heart failure: Characteristics of functional, structural and molecular changes.
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2019
  • New methods to improve diagnostics, prevention, and treatment of cardiovascular diseases with focus on oxidative stress. Protection from radiation-induced heart damage. Reperfusion injury - heart transplantation
    Program: Other projects
    Duration: 1. 12. 2018 – 31. 12. 2019
  • -
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Study of the clinically relevant forms of preconditioning as an alternative method of myocardial protection against acute ischemia in the organism challenged with civilization diseases
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Multifunctional activity of calcium/calmodulin dependent protein kinase II (CaMKII) in the heart: a relevance to disturbances in heart rhythm, contractility and cellular death.
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • The effect of the lifestyle-related risk factors on the adaptive processes in the ischemic myocardium
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • Centre of excellence of SAS for research of regulatory role of nitric oxide in civilization diseases
    Program:
    Duration: 1. 8. 2011 – 30. 6. 2015
  • Sex differences in etiopathogenesis of social stress-related cardiovascular and behavioral disorders in individuals with predisposition to hypertension.
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • The effect of aliskerin loaded nanoparticles in experimental hypertension
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • Gender differences in etiopathogenesis of social stress-related cardiovascular and behavioral disorders in individuals with predisposition to hypertension
    Program: SRDA
    Duration: 1. 5. 2011 – 30. 10. 2014
  • Modulatory effect of lifestyle-related risk factors on the mechanisms of subcellular adaptation to myocardial ischemia
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2013
  • Activation of cell signaling mechanisms as a potential target of cardiac protection against ischemic injury
    Program: SRDA
    Duration: 1. 9. 2009 – 1. 9. 2013
  • Influence of hypercholesterolemia on endogenous adaptive mechanisms in early stage of diabetes: interference with hypolipidemic agents.
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2011
  • Hypertension and diabetes as the parts of metabolic syndrome: the effects of antioxidant therapy
    Program: SRDA
    Duration: 1. 6. 2008 – 31. 12. 2010
  • Hypertension and diabetes as the parts of metabolic syndrome: the effects of antioxidant therapy
    Program: SRDA
    Duration: 1. 6. 2008 – 31. 12. 2010
  • -
    Program:
    Duration: 1. 1. 2007 – 31. 12. 2010
  • Cell signaling pathways and transcription factor activation in adaptive processes in the myocardium as an alternative approach to antiischemic protection
    Program: VEGA
    Duration: 1. 1. 2008 – 1. 12. 2010
  • -
    Program: VEGA
    Duration: 1. 1. 2007 – 1. 12. 2009
  • Role of bioflavonoids in prevention of social stress-induced hypertension
    Program: SRDA
    Duration: 1. 1. 2005 – 31. 12. 2007
  • Interactions of cell signaling mechanisms in the processes of myocardial ischemic injury and endogenous cardioprotection
    Program: VEGA
    Duration: 1. 1. 2005 – 1. 12. 2007
  • Pharmacological and non­pharmacological interventions to activate endogenous cardioprotection in failing heart.
    Program: VEGA
    Duration: 1. 1. 2025 – 0. 0. 0000
Employees